Drug
Berotralstat
Berotralstat: highest development phase Phase 3, developed by BioCryst Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- BioCryst Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| berotralstat NCT04933721 | Phase 3 | Hereditary Angioedema |
| Berotralstat NCT05453968 | Phase 3 | Hereditary Angioedema |
Latest
No recent events.
Follow Berotralstat on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.